Diagnostics company bioMerieux (PARIS:BIM) has received 510(k) clearance from the U.S. Food and Drug Administration for a test to detect and screen for methicillin-resistant staphylococcus, more ...

The FDA Dec. 5 approved the marketing of a new diagnostic test for MRSA from Roche Molecular Systems that yields results hours faster than traditional tests. MRSA is a common cause of ...

Scientists have identified a new strain of MRSA that occurs both in human and dairy cow populations and could go undetected under standard MRSA testing, according to a University of Cambridge news ...

On Monday, the U.S. Food and Drug Administration approved a new test for methicillin-resistant Staphylococcus aureus detection manufactured by Cepheid. Cepheid’s Xpert MRSA NxG test delivers ...

bioMérieux, French manufacturer of diagnostic solutions, has received FDA 510(k) approval for NucliSENS EasyQ MRSA, an automated molecular test for MRSA, according to a company news release. The test ...

The CDC estimates around 5% of U.S. hospital patients carry MRSA infections on their skin or in in their nose. In many cases, these carriers will never develop harmful infections with MRSA. However, ...

LONDON--(BUSINESS WIRE)--The global MRSA testing market is expected to grow at a CAGR of just above 11% during the forecast period, according to Technavio’s latest report. In this report, Technavio ...

July 3, 2010 — A test to detect methicillin-resistant Staphylococcus aureus (MRSA) and S aureus (SA) has been recalled by the manufacturer based on an increasing number of complaints about false ...

The US Food and Drug Administration (FDA) has approved a new, faster diagnostic test based on bacterial viability and a novel technology to detect methicillin-resistant Staphylococcus aureus (MRSA) ...

MRSA has been a major cause of concern due to the long-term use of antibiotics, which is now deemed as unnecessary. The inappropriate use of antibiotics may contribute to the rise in drug-resistant ...

SEATTLE, April 30, 2020 (GLOBE NEWSWIRE) -- According to Coherent Market Insights, the global methicillin resistant Staphylococcus aureus (MRSA) testing systems market is estimated to be valued at US$ ...

Loyola University Medical Center on Monday announced plans to start testing all incoming patients for a drug-resistant staph germ and isolating those who carry the dangerous bacteria. The 589-bed ...